PAX1 and SEPT9 methylation analyses in cervical exfoliated cells are highly efficient for detecting cervical (pre)cancer in hrHPV-positive women

References

• Arezzo, F., et al., 2021. HPV-negative cervical cancer: a narrative review. Diagnosties (Basel), 11 (6), 1–14.
   Google Scholar
• Bhat, S., et al., 2016. Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer. Biochimie, 121, 298–311.
   PubMed Web of Science ®Google Scholar
• Bogani, G., et al., 2021. High-risk HPV-positive and -negative high-grade cervical dysplasia: analysis of 5-year outcomes. Gynecologic Oncology, 161 (1), 173–178.
   PubMed Web of Science ®Google Scholar
• Bu, Q., et al., 2018. The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women. BMC Cancer, 18 (1), 1182.
   PubMed Web of Science ®Google Scholar
• Connolly, D., et al., 2011. Septin roles in tumorigenesis. Biological Chemistry, 392 (8-9), 725–738.
   PubMed Web of Science ®Google Scholar
• De Strooper, L., et al., 2018. Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: a post hoc analysis in the POBASCAM trial with 14 year follow-up. International Journal of Cancer, 143 (6), 1541–1548.
   PubMed Web of Science ®Google Scholar
• De Strooper, L.M., et al., 2014. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions. Cancer Prevention Research, 7 (12), 1251–1257.
   PubMed Web of Science ®Google Scholar
• Elfstrom, K.M., et al., 2014. Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial. BMJ (Clinical Research ed.), 348, g130.
   PubMed Web of Science ®Google Scholar
• Fang, C., et al., 2019. The promising role of PAX1 (aliases: HUP48, OFC2) gene methylation in cancer screening. Molecular Genetics & Genomic Medicine, 7 (3), e506.
   PubMed Web of Science ®Google Scholar
• Giorgi-Rossi, P., Franceschi, S., and Ronco, G., 2012. HPV prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia. International Journal of Cancer, 130 (6), 1387–1394.
   PubMed Web of Science ®Google Scholar
• Hsu, Y.W., et al., 2017. Genotype-specific methylation of HPV in cervical intraepithelial neoplasia. Journal of Gynecologic Oncology, 28 (4), e56.
   PubMed Web of Science ®Google Scholar
• Huang, J., et al., 2022. Global distribution, risk factors, and recent trends for cervical cancer: a worldwide country-level analysis. Gynecologic Oncology, 164 (1), 85–92.
   PubMed Web of Science ®Google Scholar
• Jiao, X., et al., 2019. Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance. Clinical Epigenetics, 11 (1), 120.
   PubMed Web of Science ®Google Scholar
• Kalantari, M., et al., 2014. Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: considerations for use as biomarkers of the progression of cervical neoplasia. Virology, 448, 314–321.
   PubMed Web of Science ®Google Scholar
• Katki, H.A., et al., 2013. Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results. Journal of Lower Genital Tract Disease, 17 (5 Suppl 1), S43–S49.
   PubMed Web of Science ®Google Scholar
• Kelly, H., et al., 2019. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis. British Journal of Cancer, 121 (11), 954–965.
   PubMed Web of Science ®Google Scholar
• Koeneman, M.M., et al., 2015. Natural history of high-grade cervical intraepithelial neoplasia: a review of prognostic biomarkers. Expert Review of Molecular Diagnostics, 15 (4), 527–546.
   PubMed Web of Science ®Google Scholar
• Kremer, W.W., et al., 2021. The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review. BJOG, 128 (3), 504–514.
   PubMed Web of Science ®Google Scholar
• Kuhlenbaumer, G., et al., 2005. Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nature Genetics, 37 (10), 1044–1046.
   PubMed Web of Science ®Google Scholar
• Li, B., et al., 2021. The application of PAX1 methylation detection and HPV E6/E7 mRNA detection in cervical cancer screening. Journal of Obstetrics and Gynaecology Research, 47 (8), 2720–2728.
   PubMed Web of Science ®Google Scholar
• Li, W., et al., 2022. SNHG3 affects gastric cancer development by regulating SEPT9 methylation. Journal of Oncology, 2022, 3433406.
   PubMed Web of Science ®Google Scholar
• Liang, H., et al., 2020. The application value of PAX1 and ZNF582 gene methylation in high grade intraepithelial lesion and cervical cancer. Clinical and Translational Oncology, 23 (2), 283–288.
   Google Scholar
• Liu, H., Meng, X., and Wang, J., 2020. Real time quantitative methylation detection of PAX1 gene in cervical cancer screening. International Journal of Gynecological Cancer, 30 (10), 1488–1492.
   PubMed Web of Science ®Google Scholar
• Lorincz, A.T., 2016. Virtues and weaknesses of DNA methylation as a test for cervical cancer prevention. Acta Cytologica, 60 (6), 501–512.
   PubMed Web of Science ®Google Scholar
• Louvanto, K., et al., 2015. Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16. International Journal of Cancer, 136 (6), E638–E645.
   PubMed Web of Science ®Google Scholar
• Louvanto, K., et al., 2020. Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia. Clinical Infectious Diseases, 70 (12), 2582–2590.
   PubMed Web of Science ®Google Scholar
• Luttmer, R., et al., 2016. Management of high-risk HPV-positive women for detection of cervical (pre)cancer. Expert Review of Molecular Diagnostics, 16 (9), 961–974.
   PubMed Web of Science ®Google Scholar
• Lyu, J., et al., 2020. Septin 9 methylation in nasopharyngeal swabs: a potential minimally invasive biomarker for the early detection of nasopharyngeal carcinoma. Disease Markers, 2020, 1–7.
   Web of Science ®Google Scholar
• Pal, S., Jana, S., and Bose, K., 2015. Clear cell carcinoma of cervix in a postmenopausal woman: a case report. Journal of Midlife Health, 6 (2), 85–87.
   PubMedGoogle Scholar
• Partanen, V.M., et al., 2021. Comparison of cytology and human papillomavirus-based primary testing in cervical screening programs in the Nordic countries. Journal of Medical Screening, 28 (4), 464–471.
   PubMed Web of Science ®Google Scholar
• Ronco, G., et al., 2014. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. LANCET, 383 (9916), 524–532.
   PubMed Web of Science ®Google Scholar
• Sahasrabuddhe, V.V., Luhn, P., and Wentzensen, N., 2011. Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiology, 6 (9), 1083–1098.
   PubMed Web of Science ®Google Scholar
• Sung, H., et al., 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71 (3), 209–249.
   Google Scholar
• Tian, Y., et al., 2017. Utility of gene methylation analysis, cytological examination, and HPV-16/18 genotyping in triage of high-risk human papilloma virus-positive women. Oncotarget, 8 (37), 62274–62285.
   PubMedGoogle Scholar
• Tu, J., et al., 2022. Tumor DNA methylation profiles enable diagnosis, prognosis prediction, and screening for cervical cancer. International Journal of General Medicine, 15, 5809–5821.
   PubMed Web of Science ®Google Scholar
• van den Helder, R., et al., 2022. HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer Detection. Clinical Cancer Research, 28 (10), 2061–2068.
   PubMed Web of Science ®Google Scholar
• Verhoef, V.M., et al., 2014. Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer. Gynecologic Oncology, 135 (1), 58–63.
   PubMed Web of Science ®Google Scholar
• Vink, F.J., et al., 2020. FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort. Clinical Microbiology and Infection, 27 (1), 121–125.
   Google Scholar
• Wu, W., et al., 2022. An overview of PAX1: expression, function and regulation in development and diseases. Frontiers in Cell and Developmental Biology, 10, 1051102.
   PubMed Web of Science ®Google Scholar
• Xu, W., et al., 2019. Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers. Signal Transduction and Targeted Therapy, 4, 55.
   PubMed Web of Science ®Google Scholar
• Zhang, J., et al., 2021. Effectiveness of high-risk human papillomavirus testing for cervical cancer screening in China: a multicenter, open-label, randomized clinical trial. JAMA Oncology, 7 (2), 263–270.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2022a. Detection of host cell gene/HPV DNA methylation markers: a promising triage approach for cervical cancer. Frontiers in Oncology, 12, 831949.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2022b. Triage performance and predictive value of the human gene methylation panel among women positive on self-collected HPV test: results from a prospective cohort study. International Journal of Cancer, 151 (6), 878–887.
   PubMed Web of Science ®Google Scholar
• Zhao, G., et al., 2019. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening. Cancer Medicine, 8 (12), 5619–5628.
   PubMed Web of Science ®Google Scholar